Phenolic Compound Composition of Sambucus nigra L. Wild-Growing Plants from Kosovo.

Objectives: The aim of this study was to determine the phenolic components in the flowers and leaves of wild-growing Sambucus nigra L. Materials and Methods: Plant materials were collected from eleven localities in Kosovo. Before LC-DAD-ESI-MSn analysis, an ultrasonic-assisted method with 70% methanol for 30 min extraction was used. Results: In total, 34 and 37 phenolic compounds were identified in flower and leaf extracts, respectively, with a total content of 61321.82-85961.64 mg/kg dry weight (DW) and 36136.62-93890.37 mg/kg DW. In all of the analyzed extracts, 15 phenolic acids, 20 flavonoids, one lignan, and one coumaroyl iridoid were detected. The major components were flavonoids, especially flavonols (quercetin-3-rutinoside, caffeoyl-kaempferol, and isorhamnetin-3-rutinoside), followed by phenolic acids (dicaffeoylquinic acid isomer, caffeic acid derivative, dicaffeoylquinic acid isomer, and dicaffeoylquinic acid isomer). Conclusion: In general, the methanolic extracts of flowers have shown higher polyphenolic content than those found in leaves. The multivariate statistical analysis of the phenolic content of the samples resulted in PLS-DA models with appropriate correlation coefficients of 0.903 and 0.921 for flower and leaf extracts, respectively. The models revealed distinctive clustering patterns, and the loading scatter plots depicted the unique phenolic compounds specific to each sample group.

Ribosomopathies and cancer: pharmacological implications.

INTRODUCTION: The ribosome is a ribonucleoprotein organelle responsible for protein synthesis, and its biogenesis is a highly coordinated process that involves many macromolecular components. Any acquired or inherited impairment in ribosome biogenesis or ribosomopathies is associated with the development of different cancers and rare genetic diseases. Interference with multiple steps of protein synthesis has been shown to promote tumor cell death. AREAS COVERED: We discuss the current insights about impaired ribosome biogenesis and their secondary consequences on protein synthesis, transcriptional and translational responses, proteotoxic stress, and other metabolic pathways associated with cancer and rare diseases. The modulation of different therapeutic chemical entities targeting cancer in in vitro and in vivo models have also been detailed. EXPERT OPINION: Despite the association between inherited mutations affecting ribosome biogenesis and cancer biology, the development of therapeutics targeting the essential cellular machinery has only started to emerge. New chemical entities should be designed to modulate different checkpoints (translating oncoproteins, dysregulation of specific ribosome-assembly machinery, ribosomal stress, and rewiring ribosomal functions). Although safe and effective therapies are lacking, consideration should be given to using existing drugs alone or in combination for long-term safety, with known risks for feasibility in clinical trials and synergistic effects.

Treatment benefits on metabolic syndrome with diet and physical activity.

The research has included 422 patients aged between 25 to 60, of whom 341 were men and 81 women. The purpose of research was to determine impact of diet and physical activity in the treatment of metabolic syndrome during the six month period. Processing of results through descriptive and discriminative analysis have indicated that 6 month treatment with diet and physical activity have had an impact in the: waistline decrease by 6.05 cm or 5.50% among males, and 4.92 cm or 5.10% among females; body mass index (BMI) decrease by 1.78 or 6.20% among males, and 2.3 or 8.16% among females; decrease of blood triglycerides levels by 0.35 mmol/L or 16.28% among males, and 0.27 mmol/L or 13.30% among females; increase of blood cholesterol HDL-C by 0.48 mmol/L or 34.78% among males, and 0.06 mmol/L or 4.28% among females; systolic arterial pressure decreased by 15 mmHg or 10.18%, and diastolic blood pressure by 8.74 mmHg or 9.47% among males, and systolic arterial pressure decreased by 7.39 mmHg or 5.17%, and diastolic blood pressure decreased by 5.18 mmHg or 5.75% among females; the level of blood glucose decreased by 0.45 mmol/L or 7.04% among males, and by 0.64 mmol/L or 9.92% decreased among females. The results show that physical exercise and diet are important factors in reducing the values symptoms of metabolic syndrome. In order to improve symptoms of metabolic syndrome, it is necessary to keep on with healthy diet and physical exercise that means the change of lifestyle.